Home
Alembic Pharmaceuticals Ltd Board of Directors
Board of Directors at Alembic Pharmaceuticals Ltd
Independent Director
Independent Director
Chairman & CEO
Independent Director
Independent Director
Key Highlights
- Chirayu R Amin continues to serve as the Chairman & CEO in 2024, maintaining the same position as in the previous year.
- Rajkumar Baheti continues to serve as the Director (Finance) & CFO in 2024, maintaining the same position as in the previous year.
- Pranav Amin joins the board as Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shaunak Amin joins the board as Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Archana Hingorani joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Alembic Pharmaceuticals Ltd
NSE: APLLTD
Share Price
Last Ten Days Market Price
Date | |
---|---|
11 Apr 2025 | 847.4 |
09 Apr 2025 | 839.95 |
08 Apr 2025 | 850 |
07 Apr 2025 | 844.1 |
04 Apr 2025 | 881.8 |
03 Apr 2025 | 888.9 |
02 Apr 2025 | 885.2 |
01 Apr 2025 | 897.55 |
28 Mar 2025 | 929.25 |
27 Mar 2025 | 930.9 |
Company Fundamentals for Alembic Pharmaceuticals Ltd
Market Cap
16,656 Cr
EPS
30.3
P/E Ratio (TTM)
28.0
P/B Ratio (TTM)
3.4
Day’s High
864.45
Day’s Low
832.3
DTE
0.2
ROE
13.2
52 Week High
1296.15
52 Week Low
725.6
ROCE
12.8
Market Price of Alembic Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Alembic Pharmaceuticals Ltd News Hub
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f
Read more
13 Aug 24
Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa
Read more
13 Aug 24
Alembic Pharmaceuticals Ltd leads losers in 'A' group
Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t
Read more
09 Aug 24
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J
Read more
08 Aug 24
Document
Concalls
Feb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
Transcript